GMS Infectious Diseases
Paul-Ehrlich-Gesellschaft für Infektionstherapie e.V. (PEG) (PEG)
ISSN 2195-8831
Publications
GMS Infectious Diseases
Volume 3
Brief Report
GMS Infect Dis 2015; 3:Doc03 (20151222)
[Abstract] [Full Text] [PDF]
Correlation of (1→3)-β-D-glucan with other inflammation markers in chronically HIV infected persons on suppressive antiretroviral therapy
Hoenigl M, Faria de Oliveira M, Pérez-Santiago J, Zhang Y, Woods SP, Finkelman M, Gianella SGMS Infect Dis 2015; 3:Doc03 (20151222)
[Abstract] [Full Text] [PDF]
Research Article
GMS Infect Dis 2015; 3:Doc02 (20151008)
With Erratum (Nov 3, 2015)
[Abstract] [Full Text] [PDF]
In vitro activity of ceftobiprole against key pathogens associated with pneumonia in hospitalized patients: results from the PEG surveillance study, 2010
Kresken M, Körber-Irrgang B, Kaase M, Layer F, Pfeifer Y, Werner G, Hafner D, Working Party “Antimicrobial Resistance” of the Paul Ehrlich Society for ChemotherapyGMS Infect Dis 2015; 3:Doc02 (20151008)
With Erratum (Nov 3, 2015)
[Abstract] [Full Text] [PDF]
Research Article
GMS Infect Dis 2015; 3:Doc01 (20150217)
[Abstract] [Full Text] [PDF]
Safety and outcome of treatment with voriconazole in a large cohort of immunocompromised children and adolescents
Pieper S, Kolve H, Meine T, Goletz G, Groll AHGMS Infect Dis 2015; 3:Doc01 (20150217)
[Abstract] [Full Text] [PDF]
